Selected announcement | Yum China's net income in the third quarter increased by 22% year-on-year; Yuexiu Property's sales in October increased by about 47%.

Ronshinechina: Sales in October were 0.659 billion yuan, a decrease of 61.12% year-on-year; Agile Group: Contract sales in October were 1.39 billion yuan, a decrease of about 60% year-on-year.

cls.cn19:21 ET

Grand Pharmaceutical's Phase 3 Study of Anti-Inflammatory Eye Drops Meets Clinical Endpoint

MT NewswiresNov 4 05:56 ET

Grandpharma (00512.HK): The global innovative ophthalmic drug GPN00833 has completed domestic Phase III clinical research and achieved clinical endpoints.

Grandpharma (00512.HK) announced on November 4th that the steroid nano-suspension eye drops GPN00833 for post-operative anti-inflammatory and analgesic in ophthalmology have successfully completed the Phase III clinical trial in China and achieved clinical endpoints. This marks another major milestone in the ophthalmology field for the group. The announcement stated that as one of the leading comprehensive enterprises in research, production, and sales of otorhinolaryngological drugs in China, the group ranks at the forefront in terms of the number of products in the pipeline, covering various departments such as ophthalmology, otolaryngology, and stomatology, including both chemical and traditional chinese medicine formulations.

Gelonghui FinanceNov 4 03:54 ET

Express News | Grand Pharmaceutical - Phase III Clinical Trial of Gpn00833 Conducted in China Has Completed and Successfully Met Clinical Endpoint

ReutersNov 4 03:52 ET

Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)

The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.

Zhitong FinanceNov 3 20:45 ET

Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.

①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.

cls.cnNov 1 08:59 ET